Small-Cap Momentum Watch: Upcoming Catalysts for April 13–17

From operational updates to conference participation, we’ve highlighted the small-cap events that could drive attention this week.

--

Companies Participating in the 25th Annual Needham Virtual Healthcare Conference

The 25th Annual Needham Virtual Healthcare Conference is scheduled to take place from April 13–16, 2026. This fully virtual event will feature fireside chats, company presentations, panel discussions, small group meetings, and one-on-one investor meetings across the healthcare and life sciences sectors.

Participating companies include: ● CGEN • MIST • RXRX • AVXL • ADGM • GERN • NMRA ● ESPR • SGHT • CAMP • FATE • PALI • CATX • EOLS ● SRTA • TOI • NKTX • TCRX • BDTX • LUCD • ABSI ● CGTX • NSPR

Other Companies with Material Events This Week

● ALLO > will host a conference call on April 13 at 8:30 a.m. ET to review interim futility analysis from its Phase 2 ALPHA3 trial of cema-cel in 1L LBCL

● PAPL > will report Q2 2026 financial results on April 13 (pre-market) and host a virtual fireside chat on April 16 at 11:00 a.m. ET

● CODX > executives will participate in the WTC Utah trade mission across Switzerland and Germany from April 13–22

● CCLD > will present at the AAPPR Annual Conference (April 13–15, Orlando) and showcase its Marketware platform

● ANIX > CEO will present at the RedChip Biotech virtual conference on April 16 at 3:30 p.m. ET

● AMBO > will host an open house (April 13–16, San Diego) showcasing its HybriU AI-driven phygital platform

● HOVR > will participate in the International Aerospace Innovation Forum in Montréal on April 13–14

● AVX > will present at the Centri Capital Conference on April 14 at 11:30 a.m. ET and host investor meetings

● EZRA > management will participate in the Centri Capital Conference on April 14 in New York

● SLNH > will participate in the WTR Conference (April 14–15) including a fireside chat on renewable computing strategy

● DFDV > Chief Strategy Officer will present at the Centri Capital Conference on April 14 at 1:15 p.m. ET

● CULP > will participate in a fireside chat at the WTR Conference on April 14 at 3:10 p.m. ET

● STKE > will present at the WTR Conference on April 14 at 11:10 a.m. ET covering business model and growth strategy

● MDAI > will participate in the American Burn Association Meeting (April 14–17, Orlando) showcasing DeepView®

● PHIO > CEO will present at the Centri Capital Conference on April 14 highlighting INTASYL® platform and pipeline

● CSAI > will participate in a WTR fireside chat on April 15 at 1:10 p.m. ET discussing growth and AI platform

● BTCS > CEO will present at the WTR Conference on April 14 at 1:50 p.m. ET covering DeFi strategy

● ACRS > management will participate in a fireside chat at HC Wainwright conference on April 14 at 12:00 p.m. ET

● FEAM > CEO will present at the WTR Conference on April 14 at 8:30 a.m. ET on boron strategy and growth

● OVID > will host a KCC2 R&D Day on April 14 at 9:30 a.m. ET (NY + webcast) highlighting pipeline and strategy

● XOS > will participate in TEVCON 2026 (April 14–15) including a panel on energy and charging solutions

● LFCR > will participate in the American Biomanufacturing Summit (April 14–15) at Booth 41

● VTAK > will attend the EHRA Conference in Paris from April 12–14

● PRSO > will present at the Centri Capital Conference on April 14 at 9:30 a.m. ET

● FLUX > will exhibit at MODEX 2026 (April 13–16, Atlanta) showcasing battery solutions and SkyEMS®

● AKBA > management will participate in 1x1 meetings at the Raymond James Biotech Symposium on April 14

● SKYE > will present at the GLP-1 Summit on April 16 at 1:30 p.m. on obesity treatment strategy

● NRDY > will participate in a fireside chat at the Centri Capital Conference on April 14 at 2:30 p.m. ET

● IFRX > will participate in the Raymond James Biotech Symposium on April 14 with investor meetings

● ZENA > will participate in the Centri Capital Conference on April 14

● OPTT > CEO will present at the WTR Conference on April 15 at 2:30 p.m. ET

● LFVN > management will participate in the WTR Conference on April 15

● TLSI > will present data at the SIR Annual Meeting (April 11–15, Toronto) on its PEDD™ platform

● EQ > will present EQ504 data at IMMUNOLOGY2026 (April 15–19, Boston)

● IPHA > COO will present at AACR Partnering Event on April 16 at 6:10 p.m. PT

● RNXT > will present pancreatic cancer data at SIR on April 13 at 4:45–5:45 p.m. ET

● AREC > CEO will host a virtual shareholder update webcast on April 16 at 10:00 a.m. ET

● AIM > CEO will present at a Virtual Investor Closing Bell event on April 16 at 4:00 p.m. ET

● IMUX > will present IMU-838 data at Neuroimmunology Summit on April 16 at 12:00 p.m. ET

● BIAF > will present CyPath® Lung at Cleveland Clinic symposium on April 16

● ONCY > will hold an FDA Type C meeting on April 16 to discuss registrational path in anal cancer

● PLUG > CEO will host a Reddit AMA on April 16 discussing strategy and market outlook

● CRDF > will present AACR poster on April 19 highlighting onvansertib combination data

● PLRX > will deliver an oral presentation at AACR on April 18 covering Phase 1 data

● GNPX > will present AACR poster on April 19 with Reqorsa® gene therapy data

● ACRV > will present multiple posters at AACR (April 17–22) including late-breaking data

● XAIR > will present AACR poster on April 19 with Phase 1 UNO data

● WHWK > will present oral and poster sessions at AACR on April 19 highlighting ADC pipeline

● BMR > will present a demonstration applying VISTA to validate the perceptual quality of NVIDIA RTX Video Super Resolution at NAB Show 2026, held April 18–22, 2026, in Las Vegas

● OTH > entered into a Membership Interest Purchase Agreement on February 13, 2026 to acquire Apex Marine’s dealership, service, storage, and brokerage businesses for $5.5 million, consisting of about $1.83 million in cash, approximately 670,000 common shares valued at $2.70 per share, and a $1.83 million secured seller note at 6% interest maturing in three years. Closing is expected within about 60 days of signing, around April 14, 2026, subject to due diligence and customary closing conditions

● CELU > reiterated that its strategic commercialization partnership with NEXGEL is expected to close no later than April 15, 2026, subject to customary closing conditions. The transaction is aimed at allowing CELU to focus on contract manufacturing while NEXGEL drives commercialization of placental-derived biomaterial products under improved regulatory and reimbursement clarity

● NXGL > rescheduled its shareholder update conference call to April 15, 2026 at 4:30 p.m. ET. The company said it will not finance the CELU transaction under its previously announced securities purchase agreement and is instead negotiating a new financing structure with a different investor group, with additional details on the proposed CELU transaction expected on the call

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.